$555 Million is the total value of venBio Partners LLC's 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $208,451,000 | -70.9% | 9,699,925 | 0.0% | 37.56% | -47.4% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $116,851,000 | -0.5% | 2,740,411 | -10.5% | 21.05% | +80.0% |
| New | VENTYX BIOSCIENCES INC | $99,529,000 | – | 5,011,536 | +100.0% | 17.93% | – | |
| AKRO | Sell | AKERO THERAPEUTICS INC | $45,931,000 | -6.6% | 2,171,664 | -1.3% | 8.28% | +68.9% |
| PHVS | PHARVARIS N V | $33,145,000 | -18.8% | 2,303,310 | 0.0% | 5.97% | +46.8% | |
| IMPL | IMPEL NEUROPHARMA INC | $23,817,000 | -29.1% | 2,759,791 | 0.0% | 4.29% | +28.1% | |
| ELEV | ELEVATION ONCOLOGY INC | $15,701,000 | -22.7% | 2,608,167 | 0.0% | 2.83% | +39.8% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $10,543,000 | -27.7% | 3,673,374 | 0.0% | 1.90% | +30.7% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $1,088,000 | +22.7% | 161,897 | 0.0% | 0.20% | +122.7% | |
| MTCR | Exit | METACRINE INC | $0 | – | -3,059,123 | -100.0% | -1.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.